manilatimes2h
Alterity Therapeutics Announces Positive ATH434 Phase 2 Trial Results in Multiple System Atrophy Led By Robust Clinical Efficacy
Achieved Statistical Significance with Up to 48% Slowing of Clinical Progression on UMSARS Rating Scale - MELBOURNE, Australia and SAN FRANCISCO, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Alterity ...
Alexandria Real Estate Equities' SWOT analysis: life sciences stock faces supply headwinds
Alexandria Real Estate Equities Inc. (NYSE:ARE), a leading real estate investment trust specializing in life sciences ...
Allogene Therapeutics, Inc.: Allogene Therapeutics Announces Benjamin M. Beneski as Senior Vice President and Chief Technical Officer
Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR ...
San Diego’s vacant life science labs and offices continue to grow. Will the glut peak in 2025?
The glut of life science office and lab space in San Diego County rose to an all-time high in 2024 and it’s expected to ...
Andy Dang
As the vibrant festivities of the Lunar New Year unfold this week, many of us in the Asian American, Native Hawaiian and Pacific Islander community across San Diego come together ...